135 related articles for article (PubMed ID: 31334835)
21. Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.
Megna M; Napolitano M; Balato N; Monfrecola G; Villani A; Ayala F; Balato A
Clin Exp Dermatol; 2016 Jul; 41(5):564-6. PubMed ID: 27028505
[No Abstract] [Full Text] [Related]
22. Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study.
Pugliese D; Daperno M; Fiorino G; Savarino E; Mosso E; Biancone L; Testa A; Sarpi L; Cappello M; Bodini G; Caprioli F; Festa S; Laino G; Maconi G; Mazzuoli S; Mocci G; Sartini A; D'Amore A; Alivernini S; Gremese E; Armuzzi A
Dig Liver Dis; 2019 Jul; 51(7):972-977. PubMed ID: 30992173
[TBL] [Abstract][Full Text] [Related]
23. Interstitial pneumonia in two patients with psoriasis during ustekinumab treatment.
Kikuchi S; Umezawa Y; Hayashi M; Yanaba K; Fukuchi O; Ito T; Asahina A; Saeki H; Nakagawa H
J Dermatol; 2016 Jun; 43(6):712-3. PubMed ID: 26703791
[No Abstract] [Full Text] [Related]
24. Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients.
Jones BB; Millsop JW; Walsh JA; Krueger GG; Callis Duffin K
Br J Dermatol; 2015 Jul; 173(1):272-4. PubMed ID: 25557081
[No Abstract] [Full Text] [Related]
25. Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy.
Lis-Święty A; Skrzypek-Salamon A; Arasiewicz H; Brzezińska-Wcisło L
Allergol Int; 2015 Oct; 64(4):382-3. PubMed ID: 26433537
[No Abstract] [Full Text] [Related]
26. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial.
Langley RG; Tsai TF; Flavin S; Song M; Randazzo B; Wasfi Y; Jiang J; Li S; Puig L
Br J Dermatol; 2018 Jan; 178(1):114-123. PubMed ID: 28635018
[TBL] [Abstract][Full Text] [Related]
27. Intracranial hypertension syndrome in a patient with psoriasis receiving ustekinumab.
Reyes Bueno JA; Reyes Garrido V; León A; Bustamante R
Neurologia (Engl Ed); 2019 May; 34(4):281-282. PubMed ID: 28712842
[No Abstract] [Full Text] [Related]
28. Psoriasis vulgaris complicated by eosinophilic pneumonia during ustekinumab treatment.
Yashiro M; Maejima H; Taniguchi T; Katsuoka K; Kimura M; Wada M
Eur J Dermatol; 2013; 23(3):396-7. PubMed ID: 23728153
[No Abstract] [Full Text] [Related]
29. The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.
Chiu HY; Chen CH; Wu MS; Cheng YP; Tsai TF
Br J Dermatol; 2013 Dec; 169(6):1295-303. PubMed ID: 23746170
[TBL] [Abstract][Full Text] [Related]
30. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
[No Abstract] [Full Text] [Related]
31. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
Onsun N; Yalcin B; Sallahoglu K; Rezvani A
Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
[No Abstract] [Full Text] [Related]
32. Severe disseminated Nocardia infection associated with ustekinumab treatment for psoriasis.
Couture-Cossette A; Morand M; Vinh DC; Gratton M; Martin P
Br J Dermatol; 2019 Jul; 181(1):194-195. PubMed ID: 30657168
[No Abstract] [Full Text] [Related]
33. Cutaneous protothecosis in a patient on ustekinumab for psoriasis.
Jenkinson H; Thelin L; McAndrew R; Jones KM; Talbott LB; Diven D
Int J Dermatol; 2018 Oct; 57(10):1246-1248. PubMed ID: 29603193
[No Abstract] [Full Text] [Related]
34. Translating the Science of Psoriasis.
Gordon KB
Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S64. PubMed ID: 27526392
[TBL] [Abstract][Full Text] [Related]
35. Bullous pemphigoid during ustekinumab therapy in a psoriatic patient.
Onsun N; Sallahoglu K; Dizman D; Su Ö; Tosuner Z
Eur J Dermatol; 2017 Feb; 27(1):81-82. PubMed ID: 27777186
[No Abstract] [Full Text] [Related]
36. Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.
Lund T; Thomsen SF
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28071837
[TBL] [Abstract][Full Text] [Related]
37. Severe Small-Vessel Vasculitis Temporally Associated With Administration of Ustekinumab.
MacArthur KM; Merkel PA; Van Voorhees AS; Nguyen J; Rosenbach M
J Drugs Dermatol; 2016 Mar; 15(3):359-62. PubMed ID: 26954323
[TBL] [Abstract][Full Text] [Related]
38. Case of recurrent severe cellulitis and cutaneous candidiasis during psoriasis treatment with ustekinumab.
Miyachi H; Nakamura Y; Wakabayashi S; Iwasawa MT; Oikawa A; Watanabe A; Matsue H
J Dermatol; 2017 Aug; 44(8):e206-e207. PubMed ID: 28432713
[No Abstract] [Full Text] [Related]
39. Nephrotic syndrome in relation to treatment with ustekinumab.
Pérez Fernández M; Piteiro Bermejo AB; Peña Esparragoza JK; Blasco Martínez A; Aracil Moreno I; Mancha Ramos J; Moreno Barrio F
Nefrologia (Engl Ed); 2019; 39(1):100-102. PubMed ID: 30107955
[No Abstract] [Full Text] [Related]
40. A Rare Case of Amyopathic Juvenile Dermatomyositis Associated With Psoriasis Successfully Treated With Ustekinumab.
Montoya CL; Gonzalez ML; Ospina FE; Tobón GJ
J Clin Rheumatol; 2017 Mar; 23(2):129-130. PubMed ID: 28099216
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
